Jed Latkin | CEO, CFO, and COO |
Mike Rosol | CMO |
Joel Kaufman | CBO |
Michael Okunewitch | Maxim Group |
Greeting and thank you for standing by, welcome to Navidea Biopharmaceuticals' Q3 2020 Earnings and Business Call.
During the presentation, all participants will be in a listen-only mode. Afterwards we'll conduct a question-and-answer session. [Operator Instructions] This conference is being recorded, Thursday, November 12th, 2020. And now I'd like to turn the conference over to Jed Latkin, CEO, COO, and CFO.